CIK 0001512762
- Accelerated filer
- Smaller reporting company
Coherus Oncology, Inc.
Sign in to watch- Ticker
- CHRS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 273615821
- Phone
- +1 650-649-3530
- Business address
- C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
- Former names
- Coherus BioSciences, Inc., BioGenerics, Inc.
- 4 Open-market sale Chief Scientific Officer sold 11,333 shares at an average $27.95 ($316,722)
- 4 Open-market sale Chief Financial Officer sold 3,900 shares at $28.30 ($110,365)
- 4 Open-market sale Director sold 53,583 shares at an average $27.52 ($1,474,677)
- 4 Open-market sale Chief Scientific Officer sold 11,333 shares at an average $27.40 ($310,523)
- 4 Open-market sale Chief Financial Officer sold 3,900 shares at $28.19 ($109,955)
- 4 Open-market sale Chief Scientific Officer sold 11,333 shares at $27.53 ($312,042)
- 4 Open-market sale Chief Financial Officer sold 3,900 shares at $30.62 ($119,403)
- 4 Open-market sale Chief Scientific Officer sold 11,333 shares at an average $25.69 ($291,201)
- 4 Open-market sale Chief Financial Officer sold 3,900 shares at $29.88 ($116,550)
- 4 Open-market sale President and CEO sold 4,060 shares at an average $31.75 ($128,910)
- 4 Open-market sale President and CEO sold 2,900 shares at $31.79 ($92,199)
- 4 Open-market sale Chief Scientific Officer sold 16,999 shares at $29.99 ($509,715)
- 4 Open-market sale Chief Technical Officer sold 55,621 shares at an average $30.00 ($1,668,665)
- 4 Open-market sale FMR LLC sold 100,000 shares at an average $29.86 ($2,986,216)
- 4 Open-market sale 10% owner sold 48,600 shares at an average $28.48 ($1,383,988)
- 4 Open-market sale Chief Scientific Officer sold 11,333 shares at $25.54 ($289,433)
- 4 Open-market sale Chief Technical Officer sold 3,991 shares at an average $26.13 ($104,272)
- 4 Open-market sale Chief Technical Officer sold 73,741 shares at an average $25.02 ($1,844,735)
- 4 Open-market sale Chief Technical Officer sold 43,495 shares at $20.02 ($870,931)
- 4 Exercise or conversion Chief Financial Officer acquired 1,925 shares (option exercise)
Page 15 of 20 · 399 filings